Who should be accountable for third-party access that can affect patient systems?

Accountability should sit with the teams that own both access governance and operational containment, not only procurement or vendor management. If a SaaS or external environment can influence patient systems, the organisation needs visibility, intervention rights, and escalation paths that can be exercised before a third-party issue becomes a clinical risk. Governance must include the ability to contain.

Why This Matters for Security Teams

When third-party access can influence patient systems, accountability cannot stop at the contract boundary. The real risk is not just that a supplier has access, but that no single team can prove who approved it, who monitors it, and who can shut it off when behaviour changes. That gap turns routine access into a patient safety issue and a governance failure. Current guidance from the NIST SP 800-53 Rev 5 Security and Privacy Controls reinforces that access control, monitoring, and response need named ownership, not informal handoffs.

In healthcare environments, third-party exposure often includes hosted applications, managed service providers, integration platforms, and non-human identities such as service accounts, API tokens, and automation credentials. Those identities can outlive the vendor relationship, accumulate privilege over time, and bypass normal employee lifecycle controls. That means accountability must sit with the teams that can actually govern access and intervene operationally, while procurement and vendor management support the commercial and assurance side of the relationship. In practice, many security teams encounter unsafe third-party access only after a vendor incident or integration failure has already affected clinical workflows, rather than through intentional access governance.

How It Works in Practice

Effective accountability starts by assigning clear ownership across the access lifecycle. One team should own approval standards, one should own technical enforcement, and one should own operational response. In mature environments, that usually means identity security, clinical application operations, and vendor governance each have defined duties, but only one function is accountable for the decision to allow, constrain, or revoke access. That accountability needs to include non-human identities, because machine-to-machine access often creates the deepest blind spots. The OWASP Non-Human Identity Top 10 is useful here because it highlights the risks created when secrets, tokens, and service accounts are not tracked with the same discipline as human users.

A practical control model should cover:

• Who approves third-party access and on what risk basis.
• Which systems the third party can reach, including patient-facing and clinical systems.
• How access is time-bound, reviewed, and removed when no longer needed.
• Who can suspend access immediately if telemetry, behaviour, or assurance changes.
• How non-human credentials are rotated, scoped, and traced to a business purpose.

Operationally, accountability becomes real only when the organisation can answer three questions quickly: who owns this access, what does it touch, and how is it contained if it misbehaves. That requires logging, review cadence, and escalation paths that cross IT, security, and application teams. Controls from NIST SP 800-53 Rev 5 Security and Privacy Controls help structure this with access enforcement, monitoring, and incident response expectations. These controls tend to break down when third-party access is embedded inside legacy integration pipelines because ownership is split across operations, procurement, and vendors, making emergency containment slow.

Common Variations and Edge Cases

Tighter third-party control often increases operational overhead, requiring organisations to balance clinical availability against security assurance. That tradeoff is especially visible when suppliers support critical applications that cannot tolerate frequent lockouts or manual approvals. Current guidance suggests the answer is not to relax accountability, but to define pre-approved containment paths so security teams can act without delaying care. Where there is no universal standard for this yet, organisations should treat the ability to suspend access as a required control, not an optional convenience.

Edge cases appear when a vendor is both a service provider and an integration operator, or when access is granted through shared platforms that touch multiple care teams. In those environments, accountability should still rest with the function that can enforce restrictions and coordinate response, not the entity that merely negotiated the contract. This is also where non-human identity governance becomes important: an API key or service account may be the actual path into patient systems even when the vendor has no named human operator online. Teams should distinguish between vendor assurance, which is necessary, and operational control, which is decisive when access must be contained. The practical test is simple: if the organisation cannot disable the access quickly without waiting for a supplier, accountability is not in the right place.

Related resources from NHI Mgmt Group

• Who is accountable when patient access is shared across third-party apps?
• Who is accountable when third-party access to OT systems is over-permissioned?
• Who is accountable when third-party remote access is overused in public safety environments?
• Who is accountable for third-party access after a campaign or project ends?